Jane Street
ANIK icon

Jane Street’s Anika Therapeutics ANIK Stock Holding History

Jane Street’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
85,257
+30,833
+57% +$457K ﹤0.01% 6076
2026
Q1 		$789K Sell
54,424
-80,344
-60% -$933K ﹤0.01% 7010
2025
Q4 		$1.3M Buy
134,768
+85,029
+171% +$814K ﹤0.01% 5614
2025
Q3 		$468K Buy
49,739
+26,868
+117% +$257K ﹤0.01% 8012
2025
Q2 		$242K Buy
22,871
+5,488
+32% +$69.2K ﹤0.01% 8219
2025
Q1 		$261K Sell
17,383
-10,033
-37% -$167K ﹤0.01% 8032
2024
Q4 		$451K Buy
27,416
+3,065
+13% +$60.5K ﹤0.01% 6992
2024
Q3 		$601K Buy
24,351
+8,550
+54% +$222K ﹤0.01% 6869
2024
Q2 		$400K Buy
15,801
+6,849
+77% +$178K ﹤0.01% 7366
2024
Q1 		$227K Sell
8,952
-7,601
-46% -$184K ﹤0.01% 7999
2023
Q4 		$375K Sell
16,553
-2,003
-11% -$41.4K ﹤0.01% 7274
2023
Q3 		$346K Buy
18,556
+3,735
+25% +$77.5K ﹤0.01% 6847
2023
Q2 		$385K Buy
+14,821
New +$397K ﹤0.01% 6718
2023
Q1 		– Sell
-9,151
Closed -$271K – 8958
2022
Q4 		$271K Buy
+9,151
New +$260K ﹤0.01% 7187
2021
Q2 		– Sell
-9,915
Closed -$404K – 9718
2021
Q1 		$404K Buy
+9,915
New +$376K ﹤0.01% 7186
2018
Q3 		– Sell
-9,508
Closed -$304K – 5035
2018
Q2 		$304K Buy
+9,508
New +$392K ﹤0.01% 4097
2014
Q4 		– Sell
-24,724
Closed -$906K – 2444
2014
Q3 		$906K Buy
+24,724
New +$1.07M 0.01% 993
2014
Q2 		– Sell
-39,868
Closed -$1.64M – 2514
2014
Q1 		$1.64M Buy
+39,868
New +$1.48M 0.02% 645
2013
Q4 		– Sell
-19,521
Closed -$466K – 2305
2013
Q3 		$466K Buy
+19,521
New +$438K 0.01% 1765

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Jane Street's ANIK Position: Q2 2026 in Review

Jane Street increased its Anika Therapeutics (ANIK) stake by 57% in Q2 2026, buying an estimated $457K and bringing the position to 85,257 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #6076.

Jane Street first reported a position in ANIK in Q3 2013 and has held it in 19 quarters since. The position peaked at $1.64M in Q1 2014. 134 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Jane Street held 85,257 shares of Anika Therapeutics worth $1.25M as of Q2 2026.
  • Jane Street bought 30,833 Anika Therapeutics shares in Q2 2026, an estimated $457K.
  • Anika Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6076 holding.
  • Jane Street first reported a position in Anika Therapeutics in Q3 2013 and has held it in 19 quarters since.
  • Jane Street's Anika Therapeutics position peaked at $1.64M in Q1 2014.
  • 134 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.